Coronavirus infection and immune system: An insight of COVID-19 in cancer patients

Alice Indini, Erika Rijavec, Michele Ghidini, Claudia Bareggi, Monica Cattaneo, Barbara Galassi, Donatella Gambini, Francesco Grossi

Research output: Contribution to journalReview articlepeer-review


The novel coronavirus respiratory illness (COVID-19) is a public health emergency of global concern. Patients with cancer are at high risk of infections, due to an overall immunocompromised status. However, this connection is not straightforward for coronavirus (CoV) infection, in which the host immune response is the main driver of tissue damage. We performed a thorough review of data on CoV pathogenesis and morbidity rate in cancer patients, through the analysis of the previous CoV pandemics. Considering the interaction between CoV and the host immune system, cancer patients receiving immunotherapy might be more at risk for an aberrant immune response in case of infection, and might therefore deserve additional precautions. The limited available data do not allow us to provide practical indications for the management of cancer patients in this critical situation. Efforts should be made to prospectively collect data, to identify effective interventions to guide treatment decision.

Original languageEnglish
Article number103059
JournalCritical Reviews in Oncology/Hematology
Publication statusPublished - Sep 2020


  • Cancer
  • Coronavirus
  • COVID-19
  • Immunotherapy
  • Infection
  • Oncology

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'Coronavirus infection and immune system: An insight of COVID-19 in cancer patients'. Together they form a unique fingerprint.

Cite this